Stevanto Group tackling flexible drug containment packages and filling solutions
Outsourcing Pharma
JANUARY 30, 2024
Two new offerings have been unveiled by drug delivery and solutions provider, Stevanto Group S.p.A.
Shift in the trend of Container closure integrity testing
Roots Analysis
FEBRUARY 16, 2022
In earlier times, container closure integrity testing was not regarded as an essential step in the process of manufacturing. The company developing drug product through such an intense process, use to consider container closure system only for packaging of the product. [1] Container Closure Integrity Testing Services Market.
Containment 
52
52 Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NIST publishes a beginner’s guide to DNA origami
Scienmag
JANUARY 8, 2021
Dill/NIST In a technique known as DNA origami, researchers fold long strands of DNA over and over again to construct a variety of tiny 3D structures, including miniature biosensors and drug-delivery containers.
DNA 95
95 
Stevanato Group tackling flexible drug containment packages and filling solutions
Outsourcing Pharma
JANUARY 30, 2024
Two new offerings have been unveiled by drug delivery and solutions provider, Stevanto Group S.p.A.
Containment 59
59 
FDA Warns of Dosing Errors with Compounded Semaglutide Injectables
XTalks
JULY 26, 2024
XTALKS WEBINAR: Changes are Coming to Prefilled Injectable Drug Delivery Systems Live and On-Demand: Thursday, September 12, 2024, at 1pm EDT (10am PDT) Register for this webinar today to learn more about the future of injectable drug delivery systems and the impact of blow-fill-seal technology.
Mitigating the risks of cross-contamination during Oral Solid Dose (OSD) manufacturing
Pharmaceutical Technology
FEBRUARY 3, 2023
In 2021, 72% of newly approved drugs were small molecules, and almost 50% of new drugs approved were OSD. While the industry is seeing advances in alternative drug delivery systems, oral solid doses, such as pills, capsules and soft gels, remain at the forefront of the industry.
Contamination 130
130 
Hydrocortisone by Antares Pharma for Adrenal Insufficiency: Likelihood of Approval
Pharmaceutical Technology
FEBRUARY 27, 2023
Antares Pharma’s injectables are available in disposable multi-dose pen injectors and unit dose containers. The company employs drug delivery systems to advance drug compounds and drug delivery methods. It caters its subcutaneous injection technology platforms to both generic and branded injectables.
Drug Delivery 100
100 
Leading commercial dose (non-sterile) companies in contract marketing
Pharmaceutical Technology
SEPTEMBER 20, 2022
The information contained within the download document is intended for pharmaceutical manufacturers, wholesalers, retailers and distributors, pharmaceutical executives, medical representatives, business development managers, retail salesmen, sales managers, pharmacy executives, and any other individual involved in pharmaceutical marketing.
Marketing 100
100 
Leading pharmaceutical solid dose (commercial dose) manufacturing companies in contract marketing
Pharmaceutical Technology
SEPTEMBER 8, 2022
Pharmaceutical solid dosage forms are the most popular in the pharmaceutical industry and are one of the most used drug delivery methods across patient groups. The download contains detailed information on the providers and their services and solutions, alongside contact details to aid your purchasing or hiring decision.
Manufacturing 100
100 
Vevye: A New Cyclosporine Solution for Dry Eye Disease
XTalks
JUNE 14, 2023
XTALKS WEBINAR: Drug Delivery — Evaluating Off-The-Shelf and Novel Drug Delivery Solutions Live and On-Demand: Tuesday, July 11, 2023, at 1pm EDT (10am PDT) Register for this free webinar to learn about important tradeoffs when considering an off-the-shelf (OTS) drug delivery platform vs. novel development.
Going big: How cartridges are making large-volume, high-dose subcutaneous autoinjectors a reality
Pharmaceutical Technology
APRIL 16, 2023
But with the advent of injection site absorption enhancers, drug delivery device innovations, as well as the recent primary container options, the practical subcutaneous self-administration of large-volume parenterals is becoming possible. For them, intravenous infusion in a hospital setting is the only option. autoinjector.
Protein 130
130 
A Biodegradable Nanocellulose ECG Patch: The Sustainable Alternative
XTalks
MAY 30, 2023
The patch itself is made of biodegradable nanocellulose and contains no plastic additives. The VTT Technical Research Centre of Finland has addressed this issue by developing a fully recyclable, modular ECG patch constructed from VTT’s novel cellulose e-skin material.
Stevanato Group Launches Roadshow for Proposed Initial Public Offering
BioTech 365
JULY 7, 2021
the “Company”), a leading global provider of drug containment, drug delivery and diagnostic solutions to the … Continue reading →
STAT+: Pharmalittle: Moderna must face patent claims over its Covid-19 vaccine; Pfizer and BioNTech testing combo Covid and flu shot
STAT News
NOVEMBER 3, 2022
The companies allege Moderna’s vaccine uses their technology for a drug-delivery system without permission. Citing Genevant and Arbutus sued Moderna in February, seeking royalties from Moderna’s sale of its Covid-19 vaccine. Continue to STAT+ to read the full story…
Vaccination 97
97 
Stevanato Group Announces Underwriters’ Partial Exercise of Over-Allotment Option
BioTech 365
AUGUST 17, 2021
the “Company”), a leading global provider of drug containment, drug delivery and diagnostic solutions to the … Continue reading →
Flexible grinding processes for sterile nanopharmaceutical manufacturing
Pharmaceutical Technology
OCTOBER 26, 2022
It indicates that nanomedicine also has the potential to combat the threat of antibiotic resistance via the use of nanomaterials with intrinsic antibacterial properties, as well as using nanoparticles as effective drug delivery systems for antibacterial agents. No mock-up is necessary, saving weeks of time and considerable costs.
Manufacturing 130
130 
AstraZeneca’s Airsupra Approved as First-In-Class Combo Asthma Treatment
XTalks
JANUARY 17, 2023
The US Food and Drug Administration (FDA) granted approval to AstraZeneca’s Airsupra (albuterol/budesonide), formerly known as PT027, for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of asthma attacks in individuals aged 18 years and older who have asthma.
FDA Approval 97
97 
Autoinjector: Empowering The Healthcare Industry
Roots Analysis
MAY 24, 2024
In the dynamic landscape of the healthcare sector, the evolution of drug delivery systems plays a significant role in transforming the management of chronic diseases. They are generally used in combination with primary containers, such as prefilled syringes and cartridges.
Resonant Link Develops Fastest Wireless Charger for Implantable Devices
XTalks
MAY 18, 2023
The wireless charger — the transmitter — contains a metallic coil that converts electrical energy into a magnetic field, which is then collected and reverted into electricity by the receiver inside the implanted device. Our wireless charging for titanium cans changes all of that.”
Development 96
96 
Scrub-a-Dub-Dub: FTC is Cleansing the Orange Book of Device Patents
FDA Law Blog
JUNE 13, 2024
Given that the term “finished dosage form” is defined as “tablet, capsule, or solution, that contains a drug substance, generally, but not necessarily, in association with one or more other ingredients,” and FDA has stated that dosage forms include prefilled drug delivery systems like ProAir HFA, one could argue that an inhaler-specific patent covers (..)
14th Annual Pre-Filled Syringes and Drug Devices 2022
pharmaphorum
NOVEMBER 17, 2021
The Future of Drug Delivery and Combination Product Device Design. The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to aid self-administration and deliver biologics, high concentration, and large-volume drug products.
Drugs 52
52 
BetterLife Closes Acquisition of Second Generation Psychedelic Assets of Transcend Biodynamics LLC
The Pharma Data
DECEMBER 20, 2020
With this acquisition we are expanding our product pipeline to include psychedelic therapeutics, incorporating elements of our IP around drug delivery technology in which we already have prototypes developed, which we believe will propel us towards clinical studies relatively quickly. Ahmad Doroudian, CEO of BetterLife.
XPhyto Announces RT-PCR Test for Point-of-Care COVID-19 Detection
The Pharma Data
OCTOBER 27, 2020
On April 20, 2020, XPhyto announced a definitive development, technology purchase and licence agreement with 3a-Diagnostics for the development and commercialization of real-time, low-cost and easy-to-use screening tests using 3a’s pathogen specific biosensors and XPhyto’s oral dissolvable drug delivery platform.
RNA 52
52 
Best Toenail Fungus Treatment Products
Druggist
OCTOBER 21, 2020
Curanail Once Weekly 5% Fungal Nail Treatment Curanail Once Weekly Fungal Nail treatment contains 5% of amorolfine hydrochloride as an active ingredient. delivery Excilor – review of clinical effectiveness Sleven et al. Products which were found inactive in the experiment did not contain any organic acids.
Production 98
98 
Introduction To Exosome Therapeutics
Roots Analysis
MARCH 8, 2023
Over time, various research studies have demonstrated the potential of exosomes ( membrane bound extracellular vesicles) in disease diagnosis, drug delivery and therapeutic applications. Targeted Drug Delivery: Ability to cross blood brain barrier cause lesser systemic effects and low toxicity.
RNA 52
52 
XPhyto Engages German Partner for Development of Psilocybin API Production
The Pharma Data
NOVEMBER 2, 2020
. “Psychedelic agents are a promising new class of therapeutic drug. We see a natural opportunity to apply XPhyto’s drug formulation expertise and Vektor’s proven drug delivery platforms to these emerging APIs,” said Hugh Rogers, CEO and Director of XPhyto. About XPhyto Therapeutics Corp.
Production 52
52 
BetterLife Pharma Strengthens Board of Directors
The Pharma Data
DECEMBER 28, 2020
is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. About BetterLife Pharma Inc. BetterLife Pharma Inc.
Containment 52
52 
Are All Excipients Truly Inert? Maybe Not, Suggests New Study
XTalks
JULY 28, 2020
Excipients can take many forms, such as bulking agents, binders, coatings and colourants, and they are chosen based on their ability to aid in drug delivery, administration and even in pill identification and prevention of counterfeiting. But just how inert are these excipients?
Protein 103
103 
Prefilled Syringes: Delivering Convenience and Precision in Every Dose
Roots Analysis
JANUARY 17, 2024
They offer several advantages over traditional drug delivery systems ( such as vials and syringes ), including reduced chances of dosing errors, increased patient compliance and decreased risk of microbial contamination. However, this needle system does not contain a proper locking system, therefore, increased the chances of leakage.
FOSTAIR inhaler – TOP questions & ANSWERS
Druggist
NOVEMBER 19, 2020
Formoterol, which belongs to a group of drugs called long-acting beta2-agonist ( LABA ). As we already learned from the above combination inhaler in asthma contains two ingredients, one of which is inhaled corticosteroid and the other LABA. A spacer may offer drug delivery benefits in a wider patient group. Able Spacer®.
Pharmacy 69
69 
Midatech Pharma PLC Announces Business Update
The Pharma Data
JANUARY 25, 2021
” This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014 (MAR). Midatech Pharma PLC (dual listed on LSE AIM: MTPH; and NASDAQ: MTP) isa drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines.
Containment 52
52 
TLC Announces the Appointment of Thomas H. Bliss, Jr., MBA, as Chief Business Officer
The Pharma Data
OCTOBER 20, 2020
” Mr. Bliss joins TLC following interim roles in cellular therapy, drug delivery and combination therapy where he led efforts to confirm research outcomes and partner the various technologies. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Licensing 40
40 
Valuable Leadership Styles for Pharmaceutical Executives
XTalks
AUGUST 30, 2022
Big pharmaceutical companies require a system of hierarchy to accurately adhere to the legal and regulatory requirements for drug delivery, drug approval, supply chain and manufacturing processes. Although these leadership styles are of very different natures, they also contain some commonalities.
Life Science 105
105 
XPhyto Announces Drug Formulation Strategy and 2021 Milestones Innovation to Impact
The Pharma Data
JANUARY 27, 2021
In 2020, XPhyto confirmed successful activation of its peptide-based biosensor program when delivered using Vektor’s sublingual drug delivery platform. Vektor will begin planning and development work for the incorporation of various psychedelic compounds into its drug formulations. About XPhyto Therapeutics Corp.
Drugs 52
52 
TLC Announces Completion of US$15 Million Financing for Subsidiary InspirMed Inc.
The Pharma Data
JANUARY 3, 2021
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Except as required by law, TLC expressly disclaims any responsibility to update any forward-looking statement contained herein, whether as a result of new information, future events or otherwise.
Nanoform launches technology for biologics and sets new near-term business target for 2021
The Pharma Data
NOVEMBER 26, 2020
Nanoform’s capabilities span the small to large molecule development space and the company focuses on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications. Certified Adviser: Danske Bank A/S, Finland Branch, +358 40 562 1806. For more information please visit [link].
Containment 52
52 
BetterLife Confirms Non-controlled Status of 2-bromo-LSD with Health Canada
The Pharma Data
JANUARY 18, 2021
Utilizing drug delivery platform technologies, BetterLife is refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus (HPV).
Containment 40
40 
BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies
The Pharma Data
JANUARY 27, 2021
Utilizing drug delivery platform technologies, BetterLife is refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus.
In-Vitro 52
52 
Nanoform sets a new near-term business target for 2021
The Pharma Data
JANUARY 3, 2021
Nanoform’s capabilities span the small to large molecule development space and the company focuses on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications. Certified Adviser: Danske Bank A/S, Finland Branch, +358 40 562 1806. For more information please visit [link].
Containment 40
40 Injecting Innovation: The Rising Trend of Autoinjectors in Modern Medicine
Roots Analysis
JUNE 6, 2024
Key Growth Drivers Autoinjectors Market Ease of Use: The benefits of using autoinjectors over conventional methods of parenteral drug delivery are widely recognized by healthcare industry professionals as well as end-users.
Medicine 40
40 
BetterLife’s Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic Application
The Pharma Data
DECEMBER 14, 2020
is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. About BetterLife Pharma Inc. BetterLife Pharma Inc.
Cardiovascular Systems, Inc. Announces Partnership With Chansu Vascular Techologies, LLC to Develop New Drug-Coated Balloon Technology
The Pharma Data
JANUARY 31, 2021
Dr. Marco started working on drug delivery cardiovascular devices while in charge of Medical Affairs for Abbott Vascular where, following the Perclose Inc. CSI encourages you to consider all of these risks, uncertainties and other factors carefully in evaluating the forward-looking statements contained in this release.
Development 52
52 
mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends
Roots Analysis
MARCH 16, 2023
In the last few years, researchers have become interested in using in vitro transcribed (IVT) mRNA as a drug delivery agent. mRNA drugs are considered to offer an effective alternative to gene therapies, specifically for protein replacement, as they avoid the risk of genome integration and offer strong transient expression.
Vaccination 52
52 
XPhyto Secures Exclusive Psychedelic Drug Development Agreement
The Pharma Data
NOVEMBER 9, 2020
is accelerating the next-generation drug delivery, diagnostic, and phytochemical investment opportunities: precision transdermal and oral dissolvable drug dosage forms; rapid, low-cost infectious disease and oral health screening tools; and validation of approved cannabinoid-based therapeutics focused on European markets.
Development 40
40 
Let's personalize your content